1 |
Ikeda Y, Oomori H, Koyanagi N, et al (1995). Prognostic value of combination assays for CEA and CA 19-9 in gastric cancer. Oncol, 52, 483-486.
DOI
|
2 |
Jemal A, Bray F, Center MM, et al (2011). Global Cancer Statistics. Ca Cancer J Clin, 61, 69-90.
DOI
|
3 |
Lee JC, Lee SY, Kim CY, et al (2013). Clinical utility of tumor marker cutoff ratio and a combination scoring system of preoperative carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 72-4 levels in gastric cancer. J Korean Surg Soc, 85, 283-289.
DOI
|
4 |
Li F, Li S, Wei L, et al (2013). The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment. Biomarkers, 18, 632-7.
DOI
ScienceOn
|
5 |
Liu X, Cai H, Wang Y (2012). Prognostic significance of tumor markers in T4a gastric cancer. World J Surg Oncol, 10, 68.
DOI
|
6 |
Marrelli D, Roviello F, De Stefano A, et al (1999) . Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncol, 57, 55-62.
DOI
|
7 |
Marrelli D, Pinto E, De Stefano A, et al (2001). Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer. J Surg Oncol, 78, 253-8.
DOI
|
8 |
Mattar R, Alves de Andrade CR, DiFavero GM, et al (2002). Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer. Rev Hosp Clin Fac Med Sao Paulo, 57, 89-92.
|
9 |
Park SH, Ku KB, Chung HY, et al (2008). Prognostic significance of serum and tissue carcinoembryonic antigen in patients with gastric adenocarcinomas. Cancer Res Treat, 40, 16-21.
DOI
|
10 |
Polat E, Duman U, Duman M, et al (2014) . Preoperative serum tumor marker levels in gastric cancer. Pak J Med Sci, 30, 145-149.
|
11 |
Sakamoto J, Nakazato H, Teramukai S, et al (1996). Association between preoperative plasma CEA levels and the prognosis of gastric cancer following curative resection. tumor marker committee, japanese foundation for multidisciplinary treatment of cancer, Tokyo, Japan. Surg Oncol, 5, 133-9.
DOI
|
12 |
Seregni E, Ferrari L, Martinetti A, et al (2001). Diagnostic and prognostic tumor markers in the gastrointestinal tract. Semin Surg Oncol, 20, 147-66.
DOI
|
13 |
Shimada H, Noie T, Ohashi M, et al (2014). Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the task force of the japanese gastric cancer association. Gastric Cancer, 17, 26-33.
DOI
|
14 |
Sikaroodi M, Galachiantz Y, Baranova A (2010). Tumor markers: the potential of "omics" approach. Curr Mol Med, 10, 249-57.
DOI
|
15 |
Tian SB, Yu JC, Kang WM, et al (2014). Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer. Asian Pac J Cancer Prev, 15, 6295-300.
DOI
|
16 |
Ucar E, Semerci E, Ustun H, et al (2008) . Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer. Adv Ther, 25, 1075-1084.
DOI
|
17 |
Victorzon M, Haglund C, Lundin J, et al (1995). A prognostic value of CA 19-9 but not of CEA in patients with gastric cancer. Eur J Surg Oncol, 21, 379-84.
DOI
|
18 |
Xiao J, He X, Wang Z, et al (2014). Serum carbohydrate antigen 19-9 and prognosis of patients with gastric cancer. Tumour Biol, 35, 1331-4.
DOI
|
19 |
Basbug M, Arikanoglu Z, Bulbuller N, et al (2011) . Prognostic value of preoperative CEA and CA 19-9 levels in patients with colorectal cancer. Hepatogastroenterol, 58, 400-405.
|
20 |
Ychou M, Duffour J, Kramar A, et al (2000). Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Dis Markers, 16, 105-10.
DOI
|
21 |
Chen XZ, Jiang K, Hu JK, et al (2008) . Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China. World J Gastroenterol, 14, 2715-2722.
DOI
|
22 |
Choi SR, Jang JS, Lee JH, et al (2006) . Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy. Dig Dis Sci, 51, 2081-6.
DOI
|
23 |
Dilege E, Mihmanli M, Demir U, et al (2010) . Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer. Hepatogastroenterol, 57, 674-7.
|
24 |
Duffy MJ (2007). Role of tumor markers in patients with solid cancers: a critical review. Eur J Intern Med, 18, 175-84.
DOI
|
25 |
Fan B, Xiong B (2011). Investigation of serum tumor markers in the diagnosis of gastric cancer. Hepatogastroenterol, 58, 239-45.
|
26 |
Gold P, Freedman SO (1965). Specific carcinoembryonic antigens of the human digestive system. J Exp Med, 122, 467-81.
DOI
|
27 |
Han ES, Lee HH, Lee JS, et al (2014). At which stage of gastric cancer progression do levels of carcinoembryonic antigen and carbohydrate antigen 19-9 increase? application in advanced gastric cancer treatment. J Gastric Cancer, 14, 123-8.
DOI
|
28 |
Huang ZB, Zhou X, Xu J, et al (2014) . Prognostic value of preoperative serum tumor markers in gastric cancer. World J Clin Oncol, 5, 170-6.
DOI
|
29 |
Humphris JL, Chang DK, Johns AL, et al (2012) . The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Ann Oncol, 23, 1713-22.
DOI
|